Chelsea Therapeutics Internati...

NASDAQ: CHTP
Chelsea Therapeutics is finding a serious victory from its hypotension drug. Shares hit a multiyear high after it confirmed an accelerated FDA approval of its Northera for the treatment of low blood...
Jon C. Ogg
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday February 19, 2014. They include Analog Devices, Chelsea Therapeutics, Tesla Motors and...
Jon C. Ogg
Chelsea Therapeutics International is on the leader board for percentage gains on Thursday, with a rise of 111% or so. And it isn't even on news of a buyout. Can the company live up to its potential?
Jon C. Ogg
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, January 15.
Jon C. Ogg
Source: Jon OggChelsea Therapeutics International Ltd. (NASDAQ: CHTP) is rallying on Wednesday after a report in Seeking Alpha called its Northera, a treatment for symptomatic neurogenic...
Jon C. Ogg
Source: ThinkstockWhen Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) announced that the U.S. Food & Drug Administration was going to allow the company to submit its market approval...
Jon C. Ogg
In the abbrevated trading day just before July 4, the overall stock market is up slightly. The Dow Jones Industrial Average is up 0.2%, the Nasdaq is up 0.45% and the S&P 500 is up 0.36%. Today, the...
247sam
Markets opened lower this morning but fought back on the day.  This morning’s report new unemployment benefits claims tamped down enthusiasm among investors (our coverage here). US natural gas...
Paul Ausick
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is being beaten hard this morning.  News hit that the FDA has now rejected the company’s Northera drug to treat low blood pressure for now in...
Jon C. Ogg
US stocks opened higher this morning following an in-line report from ADP on US employment gains. There was little economic news out today, but we can anticipate tomorrow’s report on new jobless...
Paul Ausick
After opening higher this morning, markets rebounded from an early dip following a better-than-expected reading on consumer confidence and a bullish report on US new home sales. But sellers took over...
Paul Ausick
Shortly after noon ET today, all three major US stock indexes are showing gains, with the DJIA up more than 24 points at about 13,009, the Nasdaq up nearly 12 points at 2,969, and the S&P 500 up...
Paul Ausick
The three major US equities indexes opened higher this morning but quickly lost steam ahead of the consumer sentiment and monthly new home sales reports. Action in Europe and Asia had boosted the...
Paul Ausick
US markets opened higher this morning and traded higher for most of the day. The DJIA briefly rose above 13,000 for the first time in nearly 3 years. But in the early afternoon, apparently as a...
Paul Ausick
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) looks dead.  In all actually, there is still some hope here.  Ultimately, the drug under question could be approved even if the FDA panel...
Jon C. Ogg